MedTrace Logo

Arterial Spin Label Depicted Ischemic Stroke Cohort (ASLIS)

NCT05920902 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-06-27

No results posted yet for this study

Summary

Establish a clinical cohort of acute ischemic stroke patients and find the determinant of the prognosis.

Conditions

  • Acute Ischemic Stroke

Interventions

OTHER

routine therapy of acute ischemia stroke

Routine therapy of acute ischemia stroke based on the guidelines, which generally includes two parts: evaluation and medicine treatment. Evaluation includes peripheral blood test, radiologic examination, electrophysiological examination, ultrasonic examination. Medicine treatment includes drug therapy and rehabilitation.

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Wei Jin, PhD. MD. · Ruijin Hospital

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05920902 on ClinicalTrials.gov